France
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
2,154.10%
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
2 |
344.74%
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
3 |
306.07%
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
4 |
223.26%
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
5 |
163.94%
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
6 |
61.33%
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
7 |
58.74%
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
8 |
47.82%
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
9 |
21.46%
|
Dec. 31, 2023 | USD 37.82 | -0.43% |
|
France |
|
10 |
16.85%
|
Dec. 31, 2023 | USD 125.57 | 1.43% |
|
France |
|
11 |
11.82%
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
12 |
11.74%
|
Dec. 31, 2023 | USD 223.78 | 0.44% |
|
France |
|
13 |
9.53%
|
Dec. 31, 2023 | USD 121.52 | 0.77% |
|
France |
|
14 |
9.10%
|
Dec. 31, 2023 | USD 26.48 | -1.30% |
|
France |
|
15 |
9.02%
|
Dec. 31, 2023 | USD 3.53 | -0.92% |
|
France |
|
16 |
7.82%
|
Dec. 31, 2023 | USD 22.89 | 0.71% |
|
France |
|
17 |
7.29%
|
Dec. 31, 2023 | USD 107.78 | 1.15% |
|
France |
|
18 |
2.76%
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
19 |
1.59%
|
June 30, 2024 | USD 3.56 | -2.04% |
|
France |
|
20 |
-2.68%
|
Dec. 31, 2023 | USD 12.48 | 0.25% |
|
France |
|
21 |
-2.94%
|
Dec. 31, 2023 | USD 2.49 | 1.52% |
|
France |
|
22 |
-4.51%
|
June 30, 2024 | USD 11.08 | 0.25% |
|
France |
|
23 |
-14.41%
|
Dec. 31, 2023 | USD 1.58 | 0.91% |
|
France |
|
24 |
-14.59%
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
25 |
-20.45%
|
Dec. 31, 2023 | USD 3.27 | -1.63% |
|
France |
|
26 |
-32.43%
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
27 |
-37.59%
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
28 |
-38.47%
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
29 |
-42.52%
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
30 |
-44.41%
|
Dec. 31, 2023 | USD 1.27 | 1.92% |
|
France |
|
31 |
-75.37%
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
32 |
-79.09%
|
Dec. 31, 2023 | USD 3.21 | 17.34% |
|
France |
|
33 |
-96.34%
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
34 |
-100.80%
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
35 |
-119.32%
|
Dec. 31, 2023 | USD 1.61 | 2.90% |
|
France |
The Healthcare company in France with the highest Return on Equity (ROE) is Nanobiotix S.A. (Paris Stock Exchange: NANO.PA) at 2,154.10%.
The Healthcare company in France with the lowest Return on Equity (ROE) is Cellectis S.A. (Paris Stock Exchange: ALCLS.PA) at -119.32%.
The top 10 Healthcare companies in France by Return on Equity (ROE) are Nanobiotix S.A., Inventiva S.A., Adocia SA, Median Technologies SA, Crossject SA, MedinCell S.A., Advicenne S.A., AB Science S.A., Equasens SA and Ipsen S.A..
The bottom 10 Healthcare companies in France by Return on Equity (ROE) are Cellectis S.A., OSE Immunotherapeutics SA, MaaT Pharma SA, Valneva SE, ABIVAX SA, ABIONYX Pharma SA, Genfit S.A., Aelis Farma SA, Valbiotis SA and Novacyt S.A..